Updates are available Correction dated 2022-05-26
Click to view Correction: https://doi.org/10.1007/978-3-030-76912-3_19
-
Authors
Cajic, Samanta https://orcid.org/0000-0001-5820-0732
Hennig, René https://orcid.org/0000-0001-9172-7982
Burock, Robert https://orcid.org/0000-0001-6372-2770
Rapp, Erdmann https://orcid.org/0000-0001-6618-2626
- License Information
-
More Information
Chapter History
First Online: 23 October 2021
Change Date: 26 May 2022
Change Type: Correction
Change Details: The original version of Chapters 4 and 15 was inadvertently published with few mistakes, and these chapters are updated with the following corrections.
Compliance with Ethical Standards
:
: Erdmann Rapp acknowledges support by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—Project-ID RA2992/1–1—Forschungsgruppe FOR 2509. Robert Burock acknowledges support by funds of the ESF.
: Author Erdmann Rapp is the founder, CEO and CSO of glyXera GmbH. Authors René Hennig and Robert Burock are employees of glyXera GmbH. glyXera provides high-performance glycoanalytical products and services and holds several patents for xCGE-LIF based glycoanalysis. Author Samanta Cajic declares no competing interests.
: This article does not contain any studies with human participants or animals performed by any of the authors.
